Lymphangiogenesis in the developing lung promoted by VEGF-A

Microvascular Research

Volumn 72, Issue 1-2, 2006, Pages 62-73

  Mallory, Bradford P ^a,b   Mead, Timothy J ^a   Wiginton, Diane A F ^a   Kulkarni, Rishikesh M ^a,b   Greenberg, James M ^a,b   Akeson, Ann L ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Lung development; Lymphangiogenesis; Lymphatic; VEGF; VEGF receptor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ADULTHOOD; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME INDUCTION; GAS EXCHANGE; HUMAN; HUMAN CELL; INJURY; LUNG DEVELOPMENT; LYMPH VESSEL; LYMPHANGIOGENESIS; MESENCHYME; MICROVASCULATURE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; RNA ANALYSIS; STIMULUS; TRANSGENICS;

ANIMALS; BETA-GALACTOSIDASE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LYMPHANGIOGENESIS; MICE; MICE, TRANSGENIC; MICROCIRCULATION; PROTEIN ISOFORMS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 33746378647     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2006.05.002     Document Type: Article

References (53)

1. Abman S.H. Bronchopulmonary dysplasia: "a vascular hypothesis". Am. J. Respir. Crit. Care Med. 164 (2001) 1755-1756
2. Akeson A.L., Greenberg J.M., Cameron J.E., Thompson F.Y., Brooks S.K., Wiginton D., and Whitsett J.A. Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev. Biol. 264 (2003) 443-455
3. Akeson A.L., Cameron J.E., Le Cras T.D., Whitsett J.A., and Greenberg J.M. Vascular endothelial growth factor-A induces prenatal neovascularization and alters bronchial development in mice. Pediatr. Res. 57 (2005) 82-88
4. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
5. Baldwin M.E., Catimel B., Nice E.C., Roufail S., Hall N.E., Stenvers K.L., Karkkainen M.J., Alitalo K., Stacker S.A., and Achen M.G. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J. Biol. Chem. 276 (2001) 19166-19171
6. Bhatt A., Pryhuber G.S., Huyck H., Watkins R.H., Metlay L.A., and Maniscalco W.M. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, flt-1, and tie-2 in human infants dying with bronchopulmonary dysplasia. Am. J. Repir. Crit. Care Med. 64 (2001) 1971-11980
7. Bland R.D., Hansen T.N., Haberkern C.M., Bressack M.A., Hazinski T.A., Raj J.U., and Goldberg R.B. Lung fluid balance in lambs before and after birth. J. Appl. Physiol. 53 (1982) 992-1004
8. Bohnsack B.L., and Hirschi K.K. Red light, green light: signals that control endothelial cell proliferation during embryonic vascular development. Cell Cycle 3 (2004) 1506-1511
9. Bolender R.P., Hyde D.M., and Dehoff R.T. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am. J. Physiol. 265 (1993) L521-L548
10. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
11. Clark J.C., Tichelaar J.W., Wert S.E., Itoh N., Perl A.K., Stahlman M.T., and Whitsett J.A. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am. J. Physiol.: Lung Cell. Mol. Physiol. 280 (2001) L705-L715
12. Clauss M. Molecular biology of the VEGF and the VEGF receptor family. Semin. Thromb. Hemostasis 26 (2000) 561-569
13. Cominetti M.R., Terruggi C.H., Ramos O.H., Fox J.W., Mariano-Oliveira A., De Freitas M.S., Figueiredo C.C., Morandi V., and Selistre-de-Araujo H.S. Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro. J. Biol. Chem. 279 (2004) 18247-18255
14. Compernolle V., Brusselmans K., Acker T., Hoet P., Tjwa M., Beck H., Plaisance S., Dor Y., Keshet E., Lupu F., Nemery B., Dewerchin M., Van Veldhoven P., Plate K., Moons L., Collen D., and Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 10 (2002) 10
15. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., D'Amore P.A., Dana M.R., Wiegand S.J., and Streilein J.W. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004) 1040-1050
16. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
17. Folpe A.L., Veikkola T., Valtola R., and Weiss S.W. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod. Pathol. 13 (2000) 180-185
18. Fong G.H., Rossant J., Gertsenstein M., and Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66-70
19. Fong G.H., Zhang L., Bryce D.M., and Peng J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Dev., Suppl. 126 (1999) 3015-3025
20. Galambos C., Ng Y.S., Ali A., Noguchi A., Lovejoy S., D'Amore P.A., and DeMello D.E. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am. J. Respir. Cell Mol. Biol. 27 (2002) 194-203
21. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273 (1998) 30336-30343
22. Greenberg J.M., Thompson F.Y., Brooks S.K., Shannon J.M., McCormick-Shannon K., Cameron J.E., Mallory B.P., and Akeson A.L. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung. Dev. Dyn. 224 (2002) 144-153
23. Han R.N., Babaei S., Robb M., Lee T., Ridsdale R., Ackerley C., Post M., and Stewart D.J. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia?. Circ. Res. 94 (2004) 1115-1123
24. Hiratsuka S., Kataoka Y., Nakao K., Nakamura K., Morikawa S., Tanaka S., Katsuki M., Maru Y., and Shibuya M. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol. Cell. Biol. 25 (2005) 355-363
25. Hong Y.K., Harvey N., Noh Y.H., Schacht V., Hirakawa S., Detmar M., and Oliver G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225 (2002) 351-357
26. Ji R.C., Miura M., Qu P., and Kato S. Expression of VEGFR-3 and 5′-nase in regenerating lymphatic vessels of the cutaneous wound healing. Microsc. Res. Tech. 64 (2004) 279-286
27. Kaner R.J., Ladetto J.V., Singh R., Fukuda N., Matthay M.A., and Crystal R.G. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22 (2000) 657-664
28. Lassus P., Ristimaki A., Ylikorkala O., Viinikka L., and Andersson S. Vascular endothelial growth factor in human preterm lung. Am. J. Respir. Crit. Care Med. 159 (1999) 1429-1433
29. Le Cras T.D., Spitzmiller R.E., Albertine K.H., Greenberg J.M., Whitsett J.A., and Akeson A.L. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am. J. Physiol.: Lung Cell. Mol. Physiol. 287 (2004) L134-L142
30. Leak L.V., and Ferrans V.J. Lymphatics and lymphoid tissue. In: Crystal R.G., and West J.B. (Eds). The Lung (1997), Raven Publishers, Philadelphia 1129-1137
31. Lee C.G., Link H., Baluk P., Homer R.J., Chapoval S., Bhandari V., Kang M.J., Cohn L., Kim Y.K., McDonald D.M., and Elias J.A. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10 (2004) 1095-1103
32. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
33. Nagy J.A., Vasile E., Feng D., Sundberg C., Brown L.F., Detmar M., Lawitts J.A., Benjamin L., Tan X., Manseau E.J., Dvorak A.M., and Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196 (2002) 1497-1506
34. Ng Y.S., Rohan R., Sunday M.E., Demello D.E., and D'Amore P.A. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. 220 (2001) 112-121
35. Ozawa C.R., Banfi A., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., McDonald D.M., and Blau H.M. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113 (2004) 516-527
36. Park J.E., Keller G.A., and Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4 (1993) 1317-1326
37. Poole T.J., Finkelstein E.B., and Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn. 220 (2001) 1-17
38. Rossant J., and Hirashima M. Vascular development and patterning: making the right choices. Curr. Opin. Genet. Dev. 13 (2003) 408-412
39. Saharinen P., and Petrova T.V. Molecular regulation of lymphangiogenesis. Ann. N. Y. Acad. Sci. 1014 (2004) 76-87
40. Sakurai Y., Ohgimoto K., Kataoka Y., Yoshida N., and Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1076-1081
41. Schachtner S., Wang Y.Q., and Baldwin H.S. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am. J. Respir. Cell Mol. Biol. 22 (2000) 157-165
42. Senger D.R., Asch B.B., Smith B.D., Perruzzi C.A., and Dvorak H.F. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 302 (1983) 714-715
43. Shehata S.M., Mooi W.J., Okazaki T., El-Banna I., Sharma H.S., and Tibboel D. Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax 54 (1999) 427-431
44. Shin D., Garcia-Cardena G., Hayashi S., Gerety S., Asahara T., Stavrakis G., Isner J., Folkman J., Gimbrone Jr. M.A., and Anderson D.J. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev. Biol. 230 (2001) 139-150
45. Sleeman J.P., Krishnan J., Kirkin V., and Baumann P. Markers for the lymphatic endothelium: in search of the holy grail?. Microsc. Res. Tech. 55 (2001) 61-69
46. Stalmans I., Ng Y.S., Fruttiger M., Bousche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., HAmmes H.P., Moons L., Dewerchin M., Collen C., Carmeliet P., and D'Amore P.A. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Ciln. Invest. 109 (2002) 327-336
47. Stenmark K.R., and Abman S.H. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu. Rev. Physiol. 67 (2004) 623-661
48. Ten Have-Opbroek A.A. Lung development in the mouse embryo. Exp. Lung Res. 17 (1991) 111-130
49. Tichelaar J.W., Lu W., and Whitsett J.A. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275 (2000) 11858-11864
50. Wang H.U., Chen Z., and Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93 (1998) 741-753
51. Zeng X., Wert S.E., Federici R., Peters K.G., and Whitsett J.A. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev. Dyn. 211 (1998) 215-2527
52. Zhou L., Lim L., Costa R.H., and Whitsett J.A. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J. Histochem. Cytochem. 44 (1996) 1183-1193
53. Zhou L., Dey C.R., Wert S.E., Yan C., Costa R.H., and Whitsett J.A. Hepatocyte nuclear factor-3beta limits cellular diversity in the developing respiratory epithelium and alters lung morphogenesis in vivo. Dev. Dyn. 210 (1997) 305-314